By Guy Rouleau and Claudia Gaspar (Eds.)
Ion channel disorder in people ends up in impairment of the excitable procedures worthy for the traditional functionality of numerous tissues, comparable to muscle and mind. It follows that increasingly more human ailments were linked to malfunctioning ion channels, a lot of that have a genetic part. This quantity offers a large and complete evaluate of the inherited channelopathies in people, together with scientific, genetic and molecular features of those stipulations, in addition to novel genomic and modeling learn techniques. additionally incorporated is a overview of power healing techniques for every of those stipulations.
Read Online or Download Ion Channel Diseases PDF
Similar molecular biology books
Ion channel disorder in people results in impairment of the excitable tactics important for the conventional functionality of a number of tissues, comparable to muscle and mind. It follows that a growing number of human illnesses were linked to malfunctioning ion channels, lots of that have a genetic part.
Wisdom of the 3-dimensional constitution of a protein is basically required for the total figuring out of its functionality. The spatial orientation of amino acids within the energetic website of an enzyme demonstrates how substrate specificity is outlined, and assists the medicinal chemist within the layout of s- cific, tight-binding inhibitors.
Viral Nanotechnology offers an up to date evaluate of the swiftly constructing box of viral nanotechnology within the parts of immunology, virology, microbiology, chemistry, physics, and mathematical modeling. Its chapters are via prime researchers and practitioners, making it either a complete and critical source for examine and learn.
Extra resources for Ion Channel Diseases
Curr. Opin. Neurol. 11(5), 469–476. , and Hirai, S. (1996). A Japanese family of autosomal dominant hypokalemic periodic paralysis with a CACNL1A3 gene mutation. Eur. J. Neurol. 3, 441–445. , and Lehmann-Horn, F. (2004). Periodic paralysis mutation MiRP2-R83H in controls: Interpretations and general recommendation. Neurology 62(6), 1012–1015. , and Lehmann-Horn, F. (2007). Genotype–phenotype correlation and therapeutic rationale in hyperkalemic periodic paralysis. Neurotherapeutics 4(2), 216–224.
George, A. , Jr, Barchi, R. , and Leppert, M. F. (1993). Sodium channel mutations in paramyotonia congenita and hyperkalemic periodic paralysis. Ann. Neurol. 33(3), 300–307. Ptacek, L. , Griggs, R. , Engel, A. , Layzer, R. , McManis, P. , et al. (1994). Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell 77(6), 863–868. Resnick, J. , Engel, W. , Griggs, R. , and Stam, A. C. (1968). Acetazolamide prophylaxis in hypokalemic periodic paralysis. N. Engl. J. Med. 278(11), 582–586.
1997). Spinal anesthesia for a patient with a calcium channel mutation causing hypokalemic periodic paralysis. Anesth. Analg. 84(2), 461–464. Hogan, K. (1998). The anesthetic myopathies and malignant hyperthermias. Curr. Opin. Neurol. 11(5), 469–476. , and Hirai, S. (1996). A Japanese family of autosomal dominant hypokalemic periodic paralysis with a CACNL1A3 gene mutation. Eur. J. Neurol. 3, 441–445. , and Lehmann-Horn, F. (2004). Periodic paralysis mutation MiRP2-R83H in controls: Interpretations and general recommendation.
Ion Channel Diseases by Guy Rouleau and Claudia Gaspar (Eds.)